Effect of exercise on body composition among women with ovarian cancer

[1]  D. Brennan,et al.  The impact of body composition on treatment in ovarian cancer: a current insight , 2021, Expert review of clinical pharmacology.

[2]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[3]  H. Kauczor,et al.  Impact of progressive resistance training on CT quantified muscle and adipose tissue compartments in pancreatic cancer patients , 2020, PloS one.

[4]  J. Lee,et al.  Sarcopenia as a Predictor of Prognosis in Early Stage Ovarian Cancer , 2020, Journal of Korean medical science.

[5]  J. Stoker,et al.  Visceral obesity and muscle mass determined by CT scan and surgical outcome in patients with advanced ovarian cancer. A retrospective cohort study. , 2020, Gynecologic oncology.

[6]  R. Newton,et al.  Resistance Exercise Dosage in Men with Prostate Cancer: Systematic Review, Meta-analysis, and Meta-regression , 2020, Medicine and science in sports and exercise.

[7]  R. Newton,et al.  Resistance training in breast cancer patients undergoing primary treatment: a systematic review and meta-regression of exercise dosage , 2020, Breast Cancer.

[8]  Amr B. Salama,et al.  Resistance Training Impact on Mobility, Muscle Strength and Lean Mass in Pancreatic Cancer Cachexia: A Randomized Controlled Trial , 2020, Clinical rehabilitation.

[9]  C. Sandler,et al.  Physical activity and exercise in women with ovarian cancer: A systematic review. , 2020, Gynecologic oncology.

[10]  F. Bozzetti.  Chemotherapy-Induced Sarcopenia , 2020, Current Treatment Options in Oncology.

[11]  S. Tomsone,et al.  Heavy Resistance Training in Breast Cancer Patients Undergoing Adjuvant Therapy. , 2019, Medicine and science in sports and exercise.

[12]  Chueh-Yi Huang,et al.  Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer. , 2019, Nutrition.

[13]  J. Kleijnen,et al.  Sarcopenia and ovarian cancer survival: a systematic review and meta‐analysis , 2019, Journal of cachexia, sarcopenia and muscle.

[14]  E. Goode,et al.  Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium , 2019, Cancer Causes & Control.

[15]  S. Cummings,et al.  D3‐Creatine dilution and the importance of accuracy in the assessment of skeletal muscle mass , 2019, Journal of cachexia, sarcopenia and muscle.

[16]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[17]  J. Koch,et al.  Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery , 2018, Annals of Surgical Oncology.

[18]  A. Jemal,et al.  Ovarian cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[19]  M. Gross,et al.  Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial , 2018, BMC Cancer.

[20]  K. Courneya,et al.  Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  M. Irwin,et al.  Randomized Trial of Exercise on Quality of Life in Women With Ovarian Cancer: Women’s Activity and Lifestyle Study in Connecticut (WALC) , 2017, Journal of the National Cancer Institute.

[22]  R. Mądry,et al.  Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival , 2017, Supportive Care in Cancer.

[23]  A. Weaver,et al.  Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer. , 2016, Gynecologic oncology.

[24]  C. Friedenreich,et al.  Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial , 2016, Breast Cancer Research and Treatment.

[25]  D. Alberts,et al.  A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology/Gynecologic Oncology Group (GOG-225) Study. , 2016, Contemporary clinical trials.

[26]  R. Beets-Tan,et al.  Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients , 2016, Journal of cachexia, sarcopenia and muscle.

[27]  A. Chagpar,et al.  Randomized Trial Comparing Telephone Versus In-Person Weight Loss Counseling on Body Composition and Circulating Biomarkers in Women Treated for Breast Cancer: The Lifestyle, Exercise, and Nutrition (LEAN) Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  E. Obermayr,et al.  Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer , 2015, PloS one.

[29]  E. Bandera,et al.  Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index. , 2015, JAMA oncology.

[30]  A. Whittemore,et al.  Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium , 2015, British Journal of Cancer.

[31]  C. Gross,et al.  Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  A. Weaver,et al.  Impact of obesity on surgical and oncologic outcomes in ovarian cancer. , 2014, Gynecologic oncology.

[33]  H. Chung,et al.  Impact of Underweight after Treatment on Prognosis of Advanced-Stage Ovarian Cancer , 2014, Journal of immunology research.

[34]  M. Ro̸rth,et al.  Safety and efficacy of resistance training in germ cell cancer patients undergoing chemotherapy: a randomized controlled trial , 2014, British Journal of Cancer.

[35]  G. Anderson,et al.  Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: results from the Women's Health Initiative. , 2014, Gynecologic oncology.

[36]  R. Newton,et al.  Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases , 2013, Prostate Cancer and Prostatic Disease.

[37]  P. Aagaard,et al.  Progressive resistance training rebuilds lean body mass in head and neck cancer patients after radiotherapy--results from the randomized DAHANCA 25B trial. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[38]  M. Buck,et al.  Obesity and Ovarian Cancer Survival: A Systematic Review and Meta-analysis , 2012, Cancer Prevention Research.

[39]  Andy H. Lee,et al.  Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies , 2012, PLoS medicine.

[40]  K. Courneya,et al.  American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. , 2010, Medicine and science in sports and exercise.

[41]  R. Speck,et al.  An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis , 2010, Journal of cancer survivorship : research and practice.

[42]  L. DiPietro,et al.  Exercise Improves Body Fat, Lean Mass, and Bone Mass in Breast Cancer Survivors , 2009, Obesity.

[43]  Tony Reiman,et al.  A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. , 2008, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[44]  D. Alberts,et al.  Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study. , 2007, Gynecologic oncology.

[45]  B. Karlan,et al.  Effect of obesity on survival in epithelial ovarian cancer , 2007, Cancer.

[46]  E. Jenison,et al.  Body weight and composition changes in ovarian cancer patients during adjuvant chemotherapy. , 2006, Gynecologic oncology.

[47]  T. Mattox.  Treatment of unintentional weight loss in patients with cancer. , 2005, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[48]  G. Molenberghs.  Applied Longitudinal Analysis , 2005 .

[49]  A. Bandura.  Social cognitive theory: an agentic perspective. , 1999, Annual review of psychology.

[50]  Lewis H Kuller,et al.  Development of Questionnaire to Examine Relationship of Physical Activity and Diabetes in Pima Indians , 1990, Diabetes Care.

[51]  D. Cramer,et al.  Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. , 1983, Journal of the National Cancer Institute.

[52]  G. Kenter,et al.  Rationale and study protocol of the Physical Activity and Dietary intervention in women with OVArian cancer (PADOVA) study , 2020 .

[53]  Nutrition and physical activity guidelines for cancer survivors , 2012, CA: a cancer journal for clinicians.